KRAS/BRAF mutation status and ERK1/2 activation as biomarkers for MEK1/2 inhibitor therapy in colorectal cancer

标题
KRAS/BRAF mutation status and ERK1/2 activation as biomarkers for MEK1/2 inhibitor therapy in colorectal cancer
作者
关键词
-
出版物
MOLECULAR CANCER THERAPEUTICS
Volume 8, Issue 4, Pages 834-843
出版商
American Association for Cancer Research (AACR)
发表日期
2009-04-17
DOI
10.1158/1535-7163.mct-08-0972

向作者/读者发起求助以获取更多资源

Discover Peeref hubs

Discuss science. Find collaborators. Network.

Join a conversation

Publish scientific posters with Peeref

Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.

Learn More